PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportshypoparathyroidism
MeSH D007011 - hypoparathyroidism
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010279:Parathyroid diseases
0 Companies
0 Drugs
Success rate
D007011: 
Hypoparathyroidism
D058165:22q11 deletion syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
RocheFolic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine Berocca Pn  1985-10-10   
SandozFolic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Vitamin a, Alpha-tocopherol, Biotin, Cholecalciferol, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Tocopherol Infuvite  2000-05-18   
OrganonAlendronate, Cholecalciferol Fosamax D  2005-04-07   
TakedaParathyroid hormone Natpar  2017-04-24   
Parathyroid hormone Natpara  2015-01-23   
Eli LillyErgocalciferol Deltalin  1982-01-01   
Sun Pharmaceutical IndustriesErgocalciferol Ergocalciferol  2009-12-29   
HospiraFolic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Phytonadione M.v.i.  1985-08-08   
Folic acid, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Phytonadione, Vitamin a, Biotin, Niacinamide, Pantothenic acid, Pyridoxine, Riboflavin, Thiamine Vitaped  1993-12-29   
Chartwell PharmaceuticalsErgocalciferol Vitamin D  1982-01-01   
Ergocalciferol Ergocalciferol  2009-05-20   
Impax LaboratoriesErgocalciferol Vitamin D  1982-01-01   
Strides Pharma GlobalErgocalciferol Ergocalciferol  2010-08-03   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
100%
2/2
Phase 2
50%
2/4
Phase 3
100%
7/7
Approved: 5Overall Success rate: 50%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
Organon
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use